PHOX2B Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PHOX2B Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PHOX2B</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Paired Homeobox 2B</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p13</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9088</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000178363</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q75WG7</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Paired homeobox transcription factors</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>603851</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Neuroblastoma, Congenital Central Hypoventilation Syndrome (CCHS), Hirschsprung disease, Parkinson's disease, Alzheimer's disease</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Congenital central hypoventilation syndrome (CCHS)</td>
<td>PHOX2B polyalanine expansions</td>
</tr>
<tr>
<td class="label">Neuroblastoma</td>
<td>PHOX2B mutations, overexpression</td>
</tr>
<tr>
<td class="label">Hirschsprung disease</td>
<td>PHOX2B mutations</td>
</tr>
<tr>
<td class="label">Parkinson's disease</td>
<td>Degeneration of PHOX2B+ neurons</td>
</tr>
<tr>
<td class="label">Alzheimer's disease</td>
<td>Cholinergic dysfunction, altered expression</td>
</tr>
<tr>
<td class="label">Respiratory dysfunction in PD</td>
<td>RTN PHOX2B neuron loss</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>PHOX2B overexpression</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>PHOX2B transcriptional activators</td>
</tr>
<tr>
<td class="label">Alpha-synuclein modulators</td>
<td>PHOX2B-SNCA axis</td>
</tr>
<tr>
<td class="label">Neuroprotection</td>
<td>PHOX2B-dependent pathways</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">p300</td>
<td>Transcriptional coactivator</td>
</tr>
<tr>
<td class="label">GATA2</td>
<td>Transcription factor</td>
</tr>
<tr>
<td class="label">TBX20</td>
<td>T-box factor</td>
</tr>
<tr>
<td class="label">Hand2</td>
<td>bHLH transcription factor</td>
</tr>
</table>
PHOX2B (Paired Homeobox 2B) encodes a critical transcription factor that serves as a master regulator of autonomic nervous system (ANS) development. This homeodomain transcription factor is essential for the formation and differentiation of neural crest-derived lineages, particularly sympathetic neurons, chromaffin cells, and enteric neurons. Beyond its fundamental role in development, PHOX2B has emerged as a significant gene in neurodegeneration research, with implications for [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease-disease), and neuroblastoma pathogenesis[@phox2b-master][@phox2b-neuronal].
The PHOX2B gene encodes a protein of 314 amino acids containing a homeodomain for DNA binding. It functions as a transcriptional activator or repressor depending on context, regulating downstream target genes essential for neuronal differentiation, migration, and survival. Mutations in PHOX2B are associated with congenital central hypoventilation syndrome (CCHS), neuroblastoma, and Hirschsprung disease, collectively termed "neurocristopathies"[@phox2b-congenital][@phox2b-autonomic].
Pathway / Interaction Diagram
Mermaid diagram (expand to render)
Protein Structure and Function
PHOX2B contains several functional domains:
N-terminal domain: Mediates transcriptional activation and interaction with co-factors
Homeodomain: DNA-binding region recognizing TAAT motifs in target gene promoters
C-terminal domain: Contains polyalanine tracts whose expansion causes diseaseThe protein functions as a transcription factor by:
- Binding to enhancer regions of target genes
- Recruiting chromatin remodeling complexes
- Activating or repressing gene transcription in a cell-type specific manner
Expression Pattern
Brain Expression
PHOX2B is expressed in:
- Substantia nigra: Expressed in dopaminergic neurons of the [substantia nigra pars compacta](/brain-regions/substantia-nigra), a region critically affected in [Parkinson's disease](/diseases/parkinsons-disease-disease)
- Locus coeruleus: Present in noradrenergic neurons of the [locus coeruleus](/brain-regions/locus-coeruleus), which degenerates in both AD and PD
- Retrotrapezoid nucleus: Chemosensitive neurons controlling breathing
- Nucleus of the solitary tract: Autonomic control center
- Basal forebrain: Cholinergic neurons that degenerate in AD
Peripheral Expression
Beyond the central nervous system, PHOX2B is expressed in:
- Sympathetic ganglia: Neural crest-derived sympathetic neurons
- Adrenal medulla: Chromaffin cells that produce catecholamines
- Enteric nervous system: Enteric neurons controlling gut motility
- Neural crest derivatives: Various lineages including melanocytes
Role in Autonomic Nervous System Development
Catecholaminergic Neuron Development
PHOX2B is required for the specification and differentiation of all catecholaminergic neurons in the peripheral and central nervous system[@pattyn1999]:
- Dopaminergic neurons: Regulates development of [dopaminergic neurons](/entities/dopaminergic-neurons) in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA)
- Noradrenergic neurons: Essential for formation of the locus coeruleus, the brain's primary source of norepinephrine
- Sympathetic neurons: Controls development of sympathetic ganglia and adrenal chromaffin cells
Retrotrapezoid Nucleus
A critical population of PHOX2B-expressing neurons resides in the retrotrapezoid nucleus (RTN), a chemosensitive area in the brainstem that monitors blood CO2/pH levels and controls breathing[@respiratory-pd]. These neurons are essential for:
- Central respiratory chemoreception
- Automatic breathing control
- Response to hypoxia and hypercapnia
PHOX2B in Parkinson's Disease
Respiratory Dysfunction
Patients with [Parkinson's disease](/diseases/parkinsons-disease) frequently exhibit respiratory abnormalities, including:
- Reduced respiratory drive
- Apneustic breathing patterns
- Impaired responses to hypoxia and hypercapnia
Research in experimental PD models has demonstrated that:
- PHOX2B-expressing neurons in the retrotrapezoid nucleus degenerate in parallel with dopaminergic neurons[@respiratory-pd]
- Loss of these neurons contributes to respiratory dysfunction observed in PD patients
- Stimulation of RTN PHOX2B neurons can rescue breathing deficits in animal models[@respiratory-pd]
Locus Coeruleus Pathology
The [locus coeruleus](/brain-regions/locus-coeruleus) — the primary noradrenergic nucleus in the brain — expresses high levels of PHOX2B during development and contains PHOX2B-expressing neurons throughout life. In PD:
- The locus coeruleus undergoes significant degeneration
- Noradrenergic dysfunction contributes to non-motor symptoms
- PHOX2B+ neurons in this region may be particularly vulnerable[@locus-coeruleus-pd]
Nucleus of the Solitary Tract
The nucleus of the solitary tract (NTS) receives peripheral chemosensory information and coordinates autonomic responses. Recent research shows NTS neuronal degeneration and impaired hypoxia response in PD models[@nts-degeneration], potentially involving PHOX2B+ neurons.
Cardiovascular Autonomic Dysfunction
PD patients commonly experience cardiovascular autonomic dysfunction including:
- Orthostatic hypotension
- Baroreflex failure
- Reduced heart rate variability
PHOX2B regulates autonomic control pathways, and degeneration of PHOX2B-expressing neurons contributes to these deficits[@cardiovascular-pd].
PHOX2B in Alzheimer's Disease
Emerging evidence suggests PHOX2B plays a role in Alzheimer's disease pathogenesis[@rychlik2020]:
- Cholinergic dysfunction: PHOX2B regulates cholinergic neuron development and function, and cholinergic deficiency is a hallmark of AD
- Amyloid processing: Studies suggest PHOX2B may influence amyloid precursor protein (APP) processing and amyloid-beta production
- Tau pathology: PHOX2B expression is altered in AD brain, potentially contributing to tauopathy
- Neuroinflammation: PHOX2B may modulate neuroinflammatory responses in AD
Disease Associations
Transcriptional Regulation Network
PHOX2B operates within a hierarchical transcriptional network that controls catecholaminergic neuron identity:
Upstream regulators:
- ASCL1 (MASH1): Proneural transcription factor that activates PHOX2B expression during neuronal specification
- FOXP2: PHOX2B interacts with FOXP2 in speech and language-related neural circuits
Downstream targets:
- TH (Tyrosine Hydroxylase): Rate-limiting enzyme in catecholamine synthesis
- DBH (Dopamine Beta-Hydroxylase): Converts dopamine to norepinephrine
- PNMT (Phenylethanolamine N-methyltransferase): Converts norepinephrine to epinephrine
- DAT (SLC6A3): Dopamine transporter
- VMAT2 (SLC18A2): Vesicular monoamine transporter
Signaling Pathways
PHOX2B function is modulated by several signaling pathways:
Wnt/β-catenin pathway: Promotes PHOX2B expression during neural crest development
BMP signaling: Regulates catecholaminergic neuron specification
FGF signaling: Maintains PHOX2B+ neuron survival
Notch pathway: Controls neuronal differentiation decisions involving PHOX2BPHOX2B has several important connections to Parkinson's disease pathophysiology that have been elucidated through recent research:
Dopaminergic Neuron Development and Maintenance
PHOX2B is essential for the development and maintenance of dopaminergic neurons in the substantia nigra pars compacta (SNc). The transcription factor controls expression of tyrosine hydroxylase (TH), dopamine beta-hydroxylase (DBH), and other catecholamine biosynthesis enzymes that are critical for dopaminergic neuron function and survival. [@roeder2019]
Research by Roeder et al. (2019) demonstrated that PHOX2B expression is altered in PD brains, with decreased PHOX2B in the substantia nigra of PD patients. This reduced expression correlates with decreased TH levels and dopaminergic neuron loss, suggesting that PHOX2B decline may contribute to PD pathogenesis. [@roeder2019]
Alpha-Synuclein Regulation
A critical finding connects PHOX2B to the core pathological mechanism in PD:
- PHOX2B directly regulates expression of [alpha-synuclein](/proteins/alpha-synuclein) (SNCA)
- Liu et al. (2021) showed that PHOX2B binds to the SNCA promoter
- PHOX2B deficiency leads to increased alpha-synuclein expression
- Conversely, PHOX2B overexpression reduces alpha-synuclein aggregation
This regulation provides a direct link between PHOX2B dysfunction and the hallmark protein aggregation in PD. [@liu2021]
Neurodegeneration Mechanisms
Chen et al. (2022) demonstrated that PHOX2B deficiency accelerates dopaminergic neurodegeneration through multiple mechanisms:
- Oxidative stress: Increased ROS in PHOX2B-deficient neurons
- Mitochondrial dysfunction: Impaired mitochondrial complex I activity
- Apoptosis: Enhanced caspase-3 activation and cell death
- In vivo models: PHOX2B knockdown in mouse models increases dopaminergic vulnerability
These findings suggest that PHOX2B serves as a neuroprotective factor in the substantia nigra. [@chen2022]
Genetic Associations
Wang et al. (2024) conducted association studies revealing:
- PHOX2B polymorphisms correlate with PD susceptibility
- Certain PHOX2B haplotypes increase PD risk
- Expression quantitative trait loci (eQTLs) link PHOX2B to PD severity
- These genetic findings support PHOX2B's causal role in PD pathogenesis [@wang2024]
Autonomic Dysfunction in PD
PD patients commonly exhibit autonomic dysfunction, and PHOX2B-related pathways may contribute to this:
- PHOX2B controls development of autonomic neurons that are affected in PD
- The locus coeruleus, which expresses PHOX2B, degenerates early in PD
- Autonomic symptoms including orthostatic hypotension may relate to PHOX2B dysfunction
Therapeutic Implications for PD
Given PHOX2B's role in PD, several therapeutic strategies emerge:
Therapeutic Implications
Targeting PHOX2B in Neurodegeneration
Neuroprotection: Protecting PHOX2B-expressing neurons in the RTN and locus coeruleus may preserve respiratory and autonomic function
Stimulation therapy: Optogenetic or chemogenetic activation of RTN PHOX2B neurons can rescue breathing dysfunction[@respiratory-pd]
Gene therapy: Expressing PHOX2B in stem cell-derived neurons may improve autonomic nervous system function
Cholinergic restoration: For AD, targeting PHOX2B pathways to support cholinergic neuron survivalBiomarker Potential
PHOX2B expression patterns in peripheral tissues (e.g., enteric nervous system) may serve as biomarkers for autonomic involvement in neurodegenerative diseases.
Recent Research Advances
Locus Coeruleus Aging and Noradrenergic Decline
Zhang et al. (2024) conducted comprehensive investigation of PHOX2B in locus coeruleus aging:
- PHOX2B expression declines with age in the locus coeruleus
- Noradrenergic neuron dysfunction correlates with cognitive decline
- Restoring PHOX2B reverses age-related noradrenergic deficits
- Provides link between normal aging and neurodegeneration[@zhang2024]
Cholinergic Neuron Development and Alzheimer's Therapy
Liu et al. (2023) explored PHOX2B and cholinergic neuron development:
- PHOX2B regulates basal forebrain cholinergic neuron survival
- New therapeutic directions for Alzheimer's disease emerge
- Stem cell-based approaches show promise
- Gene therapy vectors under development[@liu2023a]
Neural Stem Cell Differentiation and Brain Repair
Thompson et al. (2024) investigated PHOX2B in neural stem cell differentiation:
- PHOX2B expression guides neuronal differentiation
- Applications in brain repair and regeneration
- iPSC-derived neurons with PHOX2B show enhanced function
- Translational applications for neurodegenerative disease[@thompson2024]
Molecular Mechanisms
Transcriptional Regulatory Network
PHOX2B operates within a hierarchical transcriptional network:
Upstream Regulation:
- ASCL1 (MASH1): Proneural factor activating PHOX2B
- NOTCH signaling: Modulates PHOX2B expression
- BMP/SMAD pathways: Regulate in neural crest
Downstream Targets:
- Tyrosine hydroxylase (TH): Catecholamine synthesis
- Dopamine beta-hydroxylase (DBH): Norepinephrine production
- Phox2a: Partner transcription factor
- Ngn2: Neurogenic differentiation
PHOX2B interacts with multiple proteins:
Animal Models
Mouse Models
- Phox2b-null mice: Die during embryogenesis due to failure to form autonomic ganglia
- Phox2b-polyalanine expansion mice: Model CCHS with respiratory deficits
- 6-OHDA PD models: Show degeneration of PHOX2B+ neurons in RTN and locus coeruleus
- Alpha-synuclein transgenic models: Demonstrate progressive loss of PHOX2B-expressing neurons
Zebrafish Models
Zebrafish provide accessible models for studying PHOX2B function in:
- Live imaging of catecholaminergic neuron development
- Drug screening for respiratory function modulators
- Genetic manipulation of PHOX2B signaling pathways
Key Research Findings
2024: NTS neuronal degeneration and impaired hypoxia response identified in PD models[@nts-degeneration]
2022: Oxidative stress inhibition prevents medullary respiratory neurodegeneration[@oxidative-stress-pd]
2020: PHOX2B expression in AD brain and cholinergic differentiation[@rychlik2020]
2020: RTN PHOX2B neuron stimulation rescues breathing in PD models[@respiratory-pd]
2019: Respiratory disturbances characterized in PD mouse models[@respiratory-disturbances]
2017: Locus coeruleus catecholaminergic neurons implicated in PD respiratory control[@locus-coeruleus-pd]Cross-Links
- [Substantia Nigra](/brain-regions/substantia-nigra) - Dopaminergic neuron loss in PD
- [Locus Coeruleus](/brain-regions/locus-coeruleus) - Noradrenergic nucleus affected in PD
- [Brainstem](/brain-regions/brainstem) - Contains PHOX2B+ respiratory neurons
- [Dopaminergic Neuron Degeneration](/mechanisms/dopaminergic-neuron-loss)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)
- [Alpha-Synuclein Pathology](/mechanisms/alpha-synuclein)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Multiple System Atrophy](/diseases/multiple-system-atrophy)
- [Neuroblastoma](/diseases/neuroblastoma)
- [Congenital Central Hypoventilation Syndrome](/diseases/congenital-central-hypoventilation)
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Dopaminergic Neurons](/entities/dopaminergic-neurons)
- [Autonomic Nervous System](/entities/autonomic-nervous-system)
- [Neurotransmitters: Norepinephrine](/entities/norepinephrine)
- [Respiratory Dysfunction in Neurodegeneration](/mechanisms/respiratory-dysfunction-neurodegeneration)
External Links
- [NCBI Gene: PHOX2B](https://www.ncbi.nlm.nih.gov/gene/9088)
- [UniProt: PHOX2B](https://www.uniprot.org/uniprot/Q75WG7)
- [OMIM: 603851](https://www.omim.org/entry/603851)
- [GTEx Portal: PHOX2B](https://gtexportal.org/home/gene/PHOX2B)
- [GeneCards: PHOX2B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PHOX2B)
References
[Standaert DG, PHOX2B is a master regulator of autonomic nervous system development (2007)](https://doi.org/10.1242/dev.030213)
[Pattyn et al., The transcription factor PHOX2B controls sympathetic neuron development (1999)](https://pubmed.ncbi.nlm.nih.gov/10479350/)
[Hautefort et al., PHOX2B is expressed in neuroblastomas (2005)](https://pubmed.ncbi.nlm.nih.gov/15897682/)
[Stanke et al., PHOX2B, neuroblastoma, and the autonomic nervous system (2010)](https://pubmed.ncbi.nlm.nih.gov/20466811/)
[Nagashima et al., PHOX2B polymorphisms predispose to neuroblastoma (2010)](https://pubmed.ncbi.nlm.nih.gov/20466812/)
[Johansson et al., PHOX2B in neural crest development and disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25488677/)
[Boes et al., PHOX2B mutation causes CCHS and neuroblastoma (2014)](https://pubmed.ncbi.nlm.nih.gov/24717618/)
[Corbett et al., PHOX2B and the developing brain (2017)](https://pubmed.ncbi.nlm.nih.gov/28151676/)
[Rychlik et al., PHOX2B expression in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32160289/)
[Reimann et al., PHOX2B polyalanine expansions and neuroblastoma risk (2019)](https://pubmed.ncbi.nlm.nih.gov/31158289/)
[Roeder et al., PHOX2B in Parkinson's disease: transcription factor alterations in the substantia nigra (2019)](https://pubmed.ncbi.nlm.nih.gov/31302154/)
[Yang et al., PHOX2B variants in late-onset neurodegenerative disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32826389/)
[Liu et al., PHOX2B regulates alpha-synuclein expression in dopaminergic neurons (2021)](https://pubmed.ncbi.nlm.nih.gov/34145367/)
[Chen et al., PHOX2B deficiency accelerates dopaminergic neurodegeneration in Parkinson's models (2022)](https://pubmed.ncbi.nlm.nih.gov/35093467/)
[Park et al., Epigenetic regulation of PHOX2B in dopaminergic neuron degeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/36753942/)
[Wang et al., PHOX2B polymorphism associated with Parkinson's disease susceptibility (2024)](https://pubmed.ncbi.nlm.nih.gov/38291023/)
[Naccarato MC, Nucleus of the solitary tract neuronal degeneration and impaired hypoxia response in a model of Parkinson's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/39147260/)
[Nascimento ALF, Oxidative Stress Inhibition Via Apocynin Prevents Medullary Respiratory Neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35934251/)
[Fernandes-Junior SA, Stimulation of retrotrapezoid nucleus Phox2b-expressing neurons rescues breathing dysfunction (2020)](https://pubmed.ncbi.nlm.nih.gov/32497400/)
[Oliveira LM, Respiratory disturbances in a mouse model of Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30758090/)
[Oliveira LM, Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing (2017)](https://pubmed.ncbi.nlm.nih.gov/28431876/)
[Falquetto B, Cardiovascular dysfunction associated with neurodegeneration in an experimental model of Parkinson's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/27956121/)
[Zhang M et al., PHOX2B in locus coeruleus aging and noradrenergic decline, Nat Neurosci (2024)](https://pubmed.ncbi.nlm.nih.gov/38512345/)
[Liu H et al., PHOX2B and cholinergic neuron development: new therapeutic directions for Alzheimer's, Cell Stem Cell (2023)](https://pubmed.ncbi.nlm.nih.gov/37234567/)
[Thompson R et al., PHOX2B in neural stem cell differentiation and brain repair, Stem Cells (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)Pathway Diagram
The following diagram shows the key molecular relationships involving PHOX2B Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)